← SynDRA
FLUMAZENIL
SynDRA canonical compound SYN0000045 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Approval status | Approved · Rx/OTC |
|---|
| Primary target(s) | GABRQ |
|---|
| Mechanism of action | Benzodiazepine receptor antagonist |
|---|
| Indication | sedative |
|---|
| Disease area | neurology/psychiatry |
|---|
All known targets
- GABRA3
- GABRA5
- GABRA2
- GABRA1
- GABRA4
- GABRA6
- GABRG3
- GABRG1
- GABRQ
- GABRP
- GABRG2
- GABRE
Mechanisms of action (all sources)
- Benzodiazepine receptor antagonist
- GABRA1 ANTAGONIST
- GABRA2 MODULATOR
- GABRA3 MODULATOR
- GABRA4 PARTIAL AGONIST
- GABRA5 MODULATOR
- GABRA6 PARTIAL AGONIST
- TSPO ANTAGONIST
- GABRA3 MODULATOR (ALLOSTERIC MODULATOR)
- GABRA5 MODULATOR (ALLOSTERIC MODULATOR)
- GABRA2 MODULATOR (ALLOSTERIC MODULATOR)
- GABRG3 MODULATOR (ALLOSTERIC MODULATOR)
Drug classes
- Antidotes
- GABA Agents
- GABA Modulators
- Neurotransmitter Agents
- Protective Agents
- Benzodiazepine Antagonist
ATC classes
- V03A · ALL OTHER THERAPEUTIC PRODUCTS
Cross-references
Synonyms
- anexate
- flumazepil
- mazicon
- Ro-15-1788
- Flumazepil
- Lanexat
- Mazicon
- NSC-759193
- RO-15-1788/000
- RO-15-1788
- RO-151788
- RO-151788000
- RO-1722
- RO-41-8157
- Anexate
- Romazicon
- Flumazenilum
- Flumazenilo
- Flumazenilum [Latin]
- Flumazenilo [Spanish]
- Ethyl 8-fluoro-5-methyl-6-oxo-5,6-dihydro-4H-benzo[f]imidazo[1,5-a][1,4]diazepine-3-carboxylate
- [11C]flumazenil
- Ro 151788
- Flumazenil (Ro 15-1788)
- UNII-40P7XK9392
- C15H14FN3O3
- CHEMBL407
- Ro15-1788
- BRN 4763661
- MLS000028850
- Ethyl 8-fluoro-5-methyl-6-oxo-5,6-dihydro-4H-imidazo[1,5-a][1,4]benzodiazepine-3-carboxylate
- CHEBI:5103
- OFBIFZUFASYYRE-UHFFFAOYSA-N
- FlumUP TD
- Flumazenil (transdermal patch formulation)
- Flumazenil (transdermal patch formulation), Coeruleus
- Ro-15-1788/000
- flumazenil (ep monograph)
Reported adverse events
- Fear
- Death
- Arrhythmia
- Speech disorder
Look up FLUMAZENIL in the interactive SynDRA portal →